BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36399270)

  • 21. Towards dynamic genome-scale models.
    Gilbert D; Heiner M; Jayaweera Y; Rohr C
    Brief Bioinform; 2019 Jul; 20(4):1167-1180. PubMed ID: 29040409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in genome-scale metabolic models of industrially important fungi.
    Han Y; Tafur Rangel A; Pomraning KR; Kerkhoven EJ; Kim J
    Curr Opin Biotechnol; 2023 Dec; 84():103005. PubMed ID: 37797483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reconstruction of Genome-Scale Metabolic Model for Hansenula polymorpha Using RAVEN.
    Zorrilla F; Kerkhoven EJ
    Methods Mol Biol; 2022; 2513():271-290. PubMed ID: 35781211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration of probabilistic regulatory networks into constraint-based models of metabolism with applications to Alzheimer's disease.
    Yu H; Blair RH
    BMC Bioinformatics; 2019 Jul; 20(1):386. PubMed ID: 31291905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of omics data to generate and analyse COVID-19 specific genome-scale metabolic models.
    Režen T; Martins A; Mraz M; Zimic N; Rozman D; Moškon M
    Comput Biol Med; 2022 Jun; 145():105428. PubMed ID: 35339845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-Scale Brain Metabolic Networks as Scaffolds for the Systems Biology of Neurodegenerative Diseases: Mapping Metabolic Alterations.
    Özcan E; Çakır T
    Adv Neurobiol; 2018; 21():195-217. PubMed ID: 30334223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative Gene Expression and Metabolic Analysis Tool
    Grausa K; Mozga I; Pleiko K; Pentjuss A
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping the gene network landscape of Alzheimer's disease through integrating genomics and transcriptomics.
    Rosenthal SB; Wang H; Shi D; Liu C; Abagyan R; McEvoy LK; Chen CH
    PLoS Comput Biol; 2022 Feb; 18(2):e1009903. PubMed ID: 35213535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated metabolic modelling reveals cell-type specific epigenetic control points of the macrophage metabolic network.
    Pacheco MP; John E; Kaoma T; Heinäniemi M; Nicot N; Vallar L; Bueb JL; Sinkkonen L; Sauter T
    BMC Genomics; 2015 Oct; 16():809. PubMed ID: 26480823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating the deregulation of metabolic tasks via Minimum Network Enrichment Analysis (MiNEA) as applied to nonalcoholic fatty liver disease using mouse and human omics data.
    Pandey V; Hatzimanikatis V
    PLoS Comput Biol; 2019 Apr; 15(4):e1006760. PubMed ID: 31002661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational modelling of genome-scale metabolic networks and its application to CHO cell cultures.
    Rejc Ž; Magdevska L; Tršelič T; Osolin T; Vodopivec R; Mraz J; Pavliha E; Zimic N; Cvitanović T; Rozman D; Moškon M; Mraz M
    Comput Biol Med; 2017 Sep; 88():150-160. PubMed ID: 28732234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
    González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-scale modeling of human metabolism - a systems biology approach.
    Mardinoglu A; Gatto F; Nielsen J
    Biotechnol J; 2013 Sep; 8(9):985-96. PubMed ID: 23613448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized Protein-Protein Interaction Networks Towards Unraveling the Molecular Mechanisms of Alzheimer's Disease.
    Ceylan B; Düz E; Çakir T
    Mol Neurobiol; 2024 Apr; 61(4):2120-2135. PubMed ID: 37855983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-scale metabolic models as platforms for identification of novel genes as antimicrobial drug targets.
    Mienda BS; Salihu R; Adamu A; Idris S
    Future Microbiol; 2018 Mar; 13():455-467. PubMed ID: 29469596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shared genetic architecture between metabolic traits and Alzheimer's disease: a large-scale genome-wide cross-trait analysis.
    Zhu Z; Lin Y; Li X; Driver JA; Liang L
    Hum Genet; 2019 Mar; 138(3):271-285. PubMed ID: 30805717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reporter pathway analysis from transcriptome data: Metabolite-centric versus Reaction-centric approach.
    Çakır T
    Sci Rep; 2015 Sep; 5():14563. PubMed ID: 26411587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. StanDep: Capturing transcriptomic variability improves context-specific metabolic models.
    Joshi CJ; Schinn SM; Richelle A; Shamie I; O'Rourke EJ; Lewis NE
    PLoS Comput Biol; 2020 May; 16(5):e1007764. PubMed ID: 32396573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
    Hu YS; Xin J; Hu Y; Zhang L; Wang J
    Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks.
    Wruck W; Schröter F; Adjaye J
    J Alzheimers Dis; 2016; 50(4):1065-82. PubMed ID: 26890743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.